TickerFacts.

Immuneering Corp (IMRX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

44.01M
Year ended 2025-12-31
+18.6%
3-year compound annual growth
2020-12-31: 4.95M2021-12-31: 13.61M2022-12-31: 26.39M2023-12-31: 28.42M2024-12-31: 29.98M2025-12-31: 44.01M44.01M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3144.01M+46.8%2026-03-06, From 2025-01-01
2024-12-3129.98M+5.5%2026-03-06, From 2024-01-01
2023-12-3128.42M+7.7%2025-03-20, From 2023-01-01
2022-12-3126.39Mn/c2024-03-01, From 2022-01-01
2021-12-3113.61M+175.0%2023-03-06, From 2021-01-01
2020-12-314.95Mn/a2022-03-10, From 2020-01-01